Biosense Webster Indication

Tailor your approach and deliver lasting impact with the CARTO® 3 System and THERMOCOOL SMARTTOUCH® SF Catheter.1,a

grandma and grandpa

In the prospective, multicenter PRECEPT study, 80% of persistent AF patients experienced clinical success at 15 months following radiofrequency catheter ablation with the THERMOCOOL SMARTTOUCH® SF Catheter.1,2,a

Webinar

Workflow Examples

Watch this systematic approach to persistent AF

Clinical Evidence

Clinical Evidence

Learn more about the PRECEPT clinical study

Key Takeaways

Key Takeaways

Download the fact sheet